Jeffrey W. Hunter

Person

New Britain, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Humaneered anti-factor B antibody
- Patent number 9,803,005
- Issue date Oct 31, 2017
- Alexion Pharmaceuticals, Inc.
- Jeffrey W. Hunter
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A TH...
- Publication number 20240293540
- Publication date Sep 5, 2024
- Alexion Pharmaceuticals, Inc.
- Jeffrey William Hunter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KIDNEY ACTIVE FUSION PROTEINS AND METHODS OF TREATMENT USING THE SAME
- Publication number 20240262877
- Publication date Aug 8, 2024
- Alexion Pharmaceuticals, Inc.
- Keith Bouchard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEMENT FACTOR H AND Fc BINDING DOMAIN FUSION PROTEINS
- Publication number 20240254177
- Publication date Aug 1, 2024
- Alexion Pharmaceuticals, Inc.
- Krista K. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS
- Publication number 20220324952
- Publication date Oct 13, 2022
- Alexion Pharmaceuticals, Inc.
- Bruce Andrien
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-ALK2 ANTIBODIES AND USES THEREOF
- Publication number 20220098310
- Publication date Mar 31, 2022
- Alexion Pharmaceuticals, Inc.
- Jeffrey William Hunter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT DYSREGULATION US...
- Publication number 20220009979
- Publication date Jan 13, 2022
- Alexion Pharmaceuticals, Inc.
- Julian Chandler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF PRODUCING ANTI-C5 ANTIBODIES
- Publication number 20210122806
- Publication date Apr 29, 2021
- Hunter F. MALANSON
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A TH...
- Publication number 20200023060
- Publication date Jan 23, 2020
- Alexion Pharmaceuticals, Inc.
- Jeffrey William Hunter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS
- Publication number 20170073399
- Publication date Mar 16, 2017
- Alexion Pharmaceuticals, Inc.
- Bruce Andrien
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A TH...
- Publication number 20160051673
- Publication date Feb 25, 2016
- Alexion Pharmaceuticals, Inc.
- Jeffrey W. HUNTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMANEERED ANTI-FACTOR B ANTIBODY
- Publication number 20150166643
- Publication date Jun 18, 2015
- Jeffrey W. Hunter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDES THAT BIND TO HUMAN COMPLEMENT COMPONENT C5
- Publication number 20130273052
- Publication date Oct 17, 2013
- Alexion Pharmaceuticals, Inc.
- David Gies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jeffrey W. Hunter

Person

Patents Grantslast 30 patents

Humaneered anti-factor B antibody

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A TH...

KIDNEY ACTIVE FUSION PROTEINS AND METHODS OF TREATMENT USING THE SAME

COMPLEMENT FACTOR H AND Fc BINDING DOMAIN FUSION PROTEINS

RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS

ANTI-ALK2 ANTIBODIES AND USES THEREOF

FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT DYSREGULATION US...

METHODS OF PRODUCING ANTI-C5 ANTIBODIES

COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A TH...

RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS

COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A TH...

HUMANEERED ANTI-FACTOR B ANTIBODY

POLYPEPTIDES THAT BIND TO HUMAN COMPLEMENT COMPONENT C5